Gilead Sciences (GILD ... shows that these estimate changes are directly correlated with near-term stockprices. To capitalize on this, we've crafted the Zacks Rank, a unique model that ...
GILD) on Thursday, and this drove its stockprice up by almost 3% that trading session. A late-stage clinical trial of an investigational drug yielded encouraging initial results, hence the rise ...
Yee notes that while Gilead's stock has not moved much over the last few years, it will likely take off as it moves forward with its new HIV prevention drug. "They have announced this week a ...
Results that may be inaccessible to you are currently showing.